Cardio Diagnostics (CDIO) Revenue & Revenue Breakdown
Cardio Diagnostics Revenue Highlights
0
Latest Revenue (Q)
$6.58K
Cardio Diagnostics Revenue by Period
Cardio Diagnostics Revenue by Year
Date | Revenue | Change |
---|---|---|
2023-12-31 | - | -100.00% |
2022-12-31 | $950.00 | 5.44% |
2021-12-31 | $901.00 | 100.00% |
2020-12-31 | - | - |
Cardio Diagnostics Revenue by Quarter
Date | Revenue | Change |
---|---|---|
2024-09-30 | $6.58K | -16.39% |
2024-06-30 | $7.87K | -50.59% |
2024-03-31 | $15.93K | 199.96% |
2023-12-31 | $5.31K | -47.06% |
2023-09-30 | $10.03K | 481.45% |
2023-06-30 | $1.73K | 100.00% |
2023-03-31 | - | -100.00% |
2022-12-31 | $950.00 | 100.00% |
2022-09-30 | - | 100.00% |
2022-06-30 | - | 100.00% |
2022-03-31 | - | -100.00% |
2021-12-31 | $901.00 | 100.00% |
2021-09-30 | - | 100.00% |
2021-06-30 | - | 100.00% |
2021-03-31 | - | - |
Cardio Diagnostics Peer Comparison by Revenue
Ticker | Company | Last Year Revenue | Last Quarter Revenue |
---|---|---|---|
VECT | VectivBio | $27.34M | $676.00K |
SONN | Sonnet BioTherapeutics | $147.81K | - |
AVRO | AVROBIO | - | - |
CNSP | CNS Pharmaceuticals | - | - |
CYTO | Altamira Therapeutics | - | $52.73K |
ZURA | Zura Bio | - | - |
ELEV | Elevation Oncology | - | - |
ATNF | 180 Life Sciences | - | - |
PYXS | Pyxis Oncology | - | - |
PHIO | Phio Pharmaceuticals | - | - |
ZVSA | ZyVersa Therapeutics | - | - |
IMMX | Immix Biopharma | - | - |
EFTR | eFFECTOR Therapeutics | - | - |
CDIO | Cardio Diagnostics | - | $6.58K |